Pharmavite Targets More Evidence To Support Challenged Omega-3 Claim
This article was originally published in The Rose Sheet
Executive Summary
Pharmavite will not follow NAD’s recommendation to discontinue claim its NatureMade Omega 3 Xtra Blend fish oil supplement offers “nearly 4x better absorption” than standard fish oil, but plans another clinical study supporting the statement.
You may also be interested in...
Zephrex-D Efficacy Claim Passes NAD Review After Nexafed Firm Objects
NAD says that Westport Pharmaceuticals supported claims for Zephrex-D’s rate of relief and efficacy challenged by Acura Pharmaceuticals, manufacturer of Nexafed, another nonprescription PSE drug formulated to prevent extraction of the ingredient.
In Brief: NAD Decisions, Warning Letters, EC Law Struck, “Natural” Claims Suit
Pharmavite discontinues ads; NAD looks at supplement concussion claims; FDA warns product requires NDI; Spinal Touch Formulas are unapproved new drugs – FDA; Weight-loss products unapproved, misbranded; Oklahoma law restricting contraception knocked down; and Hammer Nutrition sued over “natural” claims
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.